Understanding how special immune cells can protect transplanted kidneys from rejection
The novel role of HLA-E restricted CD8 regulatory T cells in kidney allograft rejection
This research looks at how certain immune cells might help protect transplanted kidneys from being rejected by the body.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Brigham and Women's Hospital NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project ID | NIH-11113964 on NIH RePORTER |
What this research studies
Kidney transplant rejection, especially when the body makes antibodies against the new kidney, is a major challenge for patients, and we don't have good treatments yet. Our bodies have special immune cells, called CD8 regulatory T cells, that act like peacekeepers, controlling other immune cells that can cause rejection. We've found that these peacekeeper cells recognize unique signals on the rejection-causing cells and can stop them from attacking the transplanted kidney. By learning more about how these protective cells work, we aim to develop new ways to keep transplanted kidneys healthy for longer.
Who could benefit from this research
Good fit: This research is most relevant for individuals who have received a kidney transplant or are planning to, especially those concerned about their body rejecting the new kidney.
Not a fit: Patients who have not had a kidney transplant or whose kidney issues are not related to immune rejection would likely not benefit from this particular research.
Why it matters
Potential benefit: If successful, this work could lead to new treatments that help prevent kidney transplant rejection and improve the long-term health of transplanted kidneys.
How similar studies have performed: Our team has published initial findings suggesting these immune cells play a key role in controlling rejection, making this a promising new area of focus.
Where this research is happening
Boston, United States
- Brigham and Women's Hospital — Boston, United States (Active)
Researchers
- Principal investigator: Azzi, Jamil — Brigham and Women's Hospital
- Study coordinator: Azzi, Jamil
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.